PURPOSE: To evaluate macular volume in normal and glaucomatous eyes using Optical Coherence Tomography (OCT). METHODS: Fifty eyes of 30 patients (age: 49-68); 20 eyes normal, 15 eyes with early glaucoma and 15 eyes with advanced glaucoma have been studied with the commercially available OCT unit (OCT 2000) (Humphrey Zeiss, Dublin, CA, USA). All eyes were examined at a scan length of 3.44 mm vertically across the fovea. OCT macular retinal thickness maps were used to calculate macular volume. RESULTS: We observed significant differences between groups. Normals (7.35 +/- 0.455 mm3) and early glaucoma (7.09 +/- 0.475 mm3), each had significantly greater volume than subjects with advanced glaucoma (6.678 +/- 0.455 mm3). CONCLUSIONS: Volumetric analysis of macular thickness with OCT tomograms may be a useful method of documenting and monitoring patients with early glaucoma and advanced glaucoma. In our analysis, and according to the observations of other authors, OCT macular volumes correlates significantly with glaucoma status.
PURPOSE: To evaluate macular volume in normal and glaucomatous eyes using Optical Coherence Tomography (OCT). METHODS: Fifty eyes of 30 patients (age: 49-68); 20 eyes normal, 15 eyes with early glaucoma and 15 eyes with advanced glaucoma have been studied with the commercially available OCT unit (OCT 2000) (Humphrey Zeiss, Dublin, CA, USA). All eyes were examined at a scan length of 3.44 mm vertically across the fovea. OCT macular retinal thickness maps were used to calculate macular volume. RESULTS: We observed significant differences between groups. Normals (7.35 +/- 0.455 mm3) and early glaucoma (7.09 +/- 0.475 mm3), each had significantly greater volume than subjects with advanced glaucoma (6.678 +/- 0.455 mm3). CONCLUSIONS: Volumetric analysis of macular thickness with OCT tomograms may be a useful method of documenting and monitoring patients with early glaucoma and advanced glaucoma. In our analysis, and according to the observations of other authors, OCT macular volumes correlates significantly with glaucoma status.
Authors: Michelle L Gabriele; Gadi Wollstein; Hiroshi Ishikawa; Juan Xu; Jongsick Kim; Larry Kagemann; Lindsey S Folio; Joel S Schuman Journal: Prog Retin Eye Res Date: 2010-06-11 Impact factor: 21.198
Authors: Jean-Claude Mwanza; Jonathan D Oakley; Donald L Budenz; Robert T Chang; O'Rese J Knight; William J Feuer Journal: Invest Ophthalmol Vis Sci Date: 2011-10-21 Impact factor: 4.799
Authors: Florian S M Edlinger; Laura M Schrems-Hoesl; Christian Y Mardin; Robert Laemmer; Friedrich E Kruse; Wolfgang A Schrems Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-03-09 Impact factor: 3.117
Authors: Kyung Rim Sung; Gadi Wollstein; Na Rae Kim; Jung Hwa Na; Jessica E Nevins; Chan Yun Kim; Joel S Schuman Journal: Br J Ophthalmol Date: 2012-09-27 Impact factor: 4.638
Authors: Jacek Kotowski; Lindsey S Folio; Gadi Wollstein; Hiroshi Ishikawa; Yun Ling; Richard A Bilonick; Larry Kagemann; Joel S Schuman Journal: Br J Ophthalmol Date: 2012-08-22 Impact factor: 4.638
Authors: Felipe A Medeiros; Linda M Zangwill; Luciana M Alencar; Christopher Bowd; Pamela A Sample; Remo Susanna; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2009-10-08 Impact factor: 4.799